-
1
-
-
0037366067
-
Neuroblastoma: biological insights into a clinical enigma
-
10.1038/nrc1014, 12612655
-
Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003, 3:203-216. 10.1038/nrc1014, 12612655.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 203-216
-
-
Brodeur, G.M.1
-
2
-
-
34250683435
-
Neuroblastoma
-
10.1016/S0140-6736(07)60983-0, 17586306
-
Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet 2007, 369:2106-2120. 10.1016/S0140-6736(07)60983-0, 17586306.
-
(2007)
Lancet
, vol.369
, pp. 2106-2120
-
-
Maris, J.M.1
Hogarty, M.D.2
Bagatell, R.3
Cohn, S.L.4
-
3
-
-
0036769770
-
Tyrosine kinases as targets for cancer therapy
-
10.1016/S0959-8049(02)80598-6, 12528768
-
Levitzki A. Tyrosine kinases as targets for cancer therapy. Eur J Cancer 2002, 38(Suppl 5):S11-18. 10.1016/S0959-8049(02)80598-6, 12528768.
-
(2002)
Eur J Cancer
, vol.38
, Issue.SUPPL 5
-
-
Levitzki, A.1
-
4
-
-
22044442973
-
Tyrosine Kinases as Targets for Cancer Therapy
-
10.1056/NEJMra044389, 16014887
-
Krause DS, Van Etten RA. Tyrosine Kinases as Targets for Cancer Therapy. N Engl J Med 2005, 353:172-187. 10.1056/NEJMra044389, 16014887.
-
(2005)
N Engl J Med
, vol.353
, pp. 172-187
-
-
Krause, D.S.1
Van Etten, R.A.2
-
5
-
-
27544479318
-
Role of Tyrosine Kinase Inhibitors in Cancer Therapy
-
Arora A, Scholar EM. Role of Tyrosine Kinase Inhibitors in Cancer Therapy. JPE 2005, 315:971-979.
-
(2005)
JPE
, vol.315
, pp. 971-979
-
-
Arora, A.1
Scholar, E.M.2
-
6
-
-
61749085561
-
Tyrosine kinase blockers: new hope for successful cancer therapy
-
Pytel D, Sliwinski T, Poplawski T, Ferriola D, Majsterek I. Tyrosine kinase blockers: new hope for successful cancer therapy. Anticancer Agents Med Chem 2009, 9(1):66-76.
-
(2009)
Anticancer Agents Med Chem
, vol.9
, Issue.1
, pp. 66-76
-
-
Pytel, D.1
Sliwinski, T.2
Poplawski, T.3
Ferriola, D.4
Majsterek, I.5
-
7
-
-
7944236785
-
Src family kinases, key regulators of signal transduction
-
10.1038/sj.onc.1208160, 15489908
-
Parsons SJ, Parsons JT. Src family kinases, key regulators of signal transduction. Oncogene 2004, 23:7906-7909. 10.1038/sj.onc.1208160, 15489908.
-
(2004)
Oncogene
, vol.23
, pp. 7906-7909
-
-
Parsons, S.J.1
Parsons, J.T.2
-
8
-
-
33750076068
-
The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors
-
10.1002/cncr.22215, 16986126
-
Alvarez RH, Kantarjian HM, Cortes JE. The role of Src in solid and hematologic malignancies: development of new-generation Src inhibitors. Cancer 2006, 107(8):1918-1929. 10.1002/cncr.22215, 16986126.
-
(2006)
Cancer
, vol.107
, Issue.8
, pp. 1918-1929
-
-
Alvarez, R.H.1
Kantarjian, H.M.2
Cortes, J.E.3
-
9
-
-
51449088226
-
Src and focal adhesion kinase as therapeutic targets in cancer
-
10.1016/j.coph.2008.06.012, 18625340
-
Brunton VG, Frame MC. Src and focal adhesion kinase as therapeutic targets in cancer. Curr Opin Pharmacol 2008, 8:427-432. 10.1016/j.coph.2008.06.012, 18625340.
-
(2008)
Curr Opin Pharmacol
, vol.8
, pp. 427-432
-
-
Brunton, V.G.1
Frame, M.C.2
-
10
-
-
1842479152
-
Kinase inhibitors and cytotoxic drug resistance
-
10.1158/1078-0432.CCR-0001-4, 15073093
-
Grant S, Dent P. Kinase inhibitors and cytotoxic drug resistance. Clin Cancer Res 2004, 10(7):2205-2207. 10.1158/1078-0432.CCR-0001-4, 15073093.
-
(2004)
Clin Cancer Res
, vol.10
, Issue.7
, pp. 2205-2207
-
-
Grant, S.1
Dent, P.2
-
11
-
-
36949032298
-
Src Family nonreceptor tyrosine kinases as molecular targets for cancer terapy
-
10.2174/187152007784111278, 18045060
-
Johnson FM, Gallick GE. Src Family nonreceptor tyrosine kinases as molecular targets for cancer terapy. Anticancer Agents Med Chem 2007, 7:651-659. 10.2174/187152007784111278, 18045060.
-
(2007)
Anticancer Agents Med Chem
, vol.7
, pp. 651-659
-
-
Johnson, F.M.1
Gallick, G.E.2
-
12
-
-
0023487246
-
Expression of c-src in cultured human neuroblastoma and small-cell lung carcinoma cell lines correlates with neurocrine differentiation
-
368098, 2830484
-
Mellström K, Bjelfman C, Hammerling U, Påhlman S. Expression of c-src in cultured human neuroblastoma and small-cell lung carcinoma cell lines correlates with neurocrine differentiation. Mol Cell Biol 1987, 7:4178-4184. 368098, 2830484.
-
(1987)
Mol Cell Biol
, vol.7
, pp. 4178-4184
-
-
Mellström, K.1
Bjelfman, C.2
Hammerling, U.3
Påhlman, S.4
-
13
-
-
0025107309
-
Expression of the neuronal form of pp60c-src in neuroblastoma in relation to clinical stage and prognosis
-
Bjelfman C, Hedborg F, Johansson I, Nordenskjold M, Palhlman S. Expression of the neuronal form of pp60c-src in neuroblastoma in relation to clinical stage and prognosis. Cancer Res 1990, 50:6908-6914.
-
(1990)
Cancer Res
, vol.50
, pp. 6908-6914
-
-
Bjelfman, C.1
Hedborg, F.2
Johansson, I.3
Nordenskjold, M.4
Palhlman, S.5
-
14
-
-
12144286142
-
Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells
-
10.1021/jm034257u, 15027847
-
Carraro F, Pucci A, Naldini A, Schenone S, Bruno O, Ranise A, Bondavalli F, Brullo C, Fossa P, Menozzi G, Mosti L, Manetti F, Botta M. Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells. J Med Chem 2004, 47:1595-1598. 10.1021/jm034257u, 15027847.
-
(2004)
J Med Chem
, vol.47
, pp. 1595-1598
-
-
Carraro, F.1
Pucci, A.2
Naldini, A.3
Schenone, S.4
Bruno, O.5
Ranise, A.6
Bondavalli, F.7
Brullo, C.8
Fossa, P.9
Menozzi, G.10
Mosti, L.11
Manetti, F.12
Botta, M.13
-
15
-
-
6344226300
-
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line
-
10.1016/j.ejmech.2004.07.010, 15501543
-
Schenone S, Bruno O, Bondavalli F, Ranise A, Mosti L, Menozzi G, Fossa P, Donnini S, Santoro A, Ziche M, Manetti F, Botta M. Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line. Eur J Med Chem 2004, 39:939-946. 10.1016/j.ejmech.2004.07.010, 15501543.
-
(2004)
Eur J Med Chem
, vol.39
, pp. 939-946
-
-
Schenone, S.1
Bruno, O.2
Bondavalli, F.3
Ranise, A.4
Mosti, L.5
Menozzi, G.6
Fossa, P.7
Donnini, S.8
Santoro, A.9
Ziche, M.10
Manetti, F.11
Botta, M.12
-
16
-
-
36148945220
-
Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice
-
10.1021/jm061449r, 17929792
-
Manetti F, Santucci A, Locatelli GA, Maga G, Spreafico A, Serchi T, Orlandini M, Bernardini G, Caradonna NP, Spallarossa A, Brullo C, Schenone S, Bruno O, Ranise A, Bondavalli F, Hoffmann O, Bologna M, Angelucci A, Botta M. Identification of a novel pyrazolo[3,4-d]pyrimidine able to inhibit cell proliferation of a human osteogenic sarcoma in vitro and in a xenograft model in mice. J Med Chem 2007, 50:5579-5588. 10.1021/jm061449r, 17929792.
-
(2007)
J Med Chem
, vol.50
, pp. 5579-5588
-
-
Manetti, F.1
Santucci, A.2
Locatelli, G.A.3
Maga, G.4
Spreafico, A.5
Serchi, T.6
Orlandini, M.7
Bernardini, G.8
Caradonna, N.P.9
Spallarossa, A.10
Brullo, C.11
Schenone, S.12
Bruno, O.13
Ranise, A.14
Bondavalli, F.15
Hoffmann, O.16
Bologna, M.17
Angelucci, A.18
Botta, M.19
-
17
-
-
33750084413
-
Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells
-
10.1016/j.ejca.2006.06.024, 16973347
-
Angelucci A, Schenone S, Gravina GL, Muzi P, Festuccia C, Vicentini C, Botta M, Bologna M. Pyrazolo[3,4-d]pyrimidines c-Src inhibitors reduce epidermal growth factor-induced migration in prostate cancer cells. Eur J Cancer 2006, 42:2838-2845. 10.1016/j.ejca.2006.06.024, 16973347.
-
(2006)
Eur J Cancer
, vol.42
, pp. 2838-2845
-
-
Angelucci, A.1
Schenone, S.2
Gravina, G.L.3
Muzi, P.4
Festuccia, C.5
Vicentini, C.6
Botta, M.7
Bologna, M.8
-
18
-
-
38449096470
-
Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates
-
Morisi R, Celano M, Tosi E, Schenone S, Navarra M, Ferretti E, Costante G, Durante C, Botta G, D'Agostino M, Brullo C, Filetti S, Botta M, Russo D. Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates. J Endocrinol Invest 2007, 30:RC31-34.
-
(2007)
J Endocrinol Invest
, vol.30
-
-
Morisi, R.1
Celano, M.2
Tosi, E.3
Schenone, S.4
Navarra, M.5
Ferretti, E.6
Costante, G.7
Durante, C.8
Botta, G.9
D'Agostino, M.10
Brullo, C.11
Filetti, S.12
Botta, M.13
Russo, D.14
-
19
-
-
45849100944
-
Cytotoxic effects of a novel pyrazolopyrimidine derivative entrapped in liposomes in anaplastic thyroid cancer cells in vitro and in xenograft tumors in vivo
-
10.1677/ERC-07-0243, 18509002
-
Celano M, Schenone S, Cosco D, Navarra M, Puxeddu E, Racanicchi L, Brullo C, Varano E, Alcaro S, Ferretti E, Botta G, Filetti S, Fresta M, Botta M, Russo D. Cytotoxic effects of a novel pyrazolopyrimidine derivative entrapped in liposomes in anaplastic thyroid cancer cells in vitro and in xenograft tumors in vivo. Endocr Relat Cancer 2008, 15:499-510. 10.1677/ERC-07-0243, 18509002.
-
(2008)
Endocr Relat Cancer
, vol.15
, pp. 499-510
-
-
Celano, M.1
Schenone, S.2
Cosco, D.3
Navarra, M.4
Puxeddu, E.5
Racanicchi, L.6
Brullo, C.7
Varano, E.8
Alcaro, S.9
Ferretti, E.10
Botta, G.11
Filetti, S.12
Fresta, M.13
Botta, M.14
Russo, D.15
-
20
-
-
77955820291
-
New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells
-
10.1096/fj.09-148593, 20354138
-
Rossi A, Schenone S, Angelucci A, Cozzi M, Caracciolo V, Pentimalli F, Puca A, Pucci B, La Montagna R, Bologna M, Botta M, Giordano A. New pyrazolo-[3,4-d]-pyrimidine derivative Src kinase inhibitors lead to cell cycle arrest and tumor growth reduction of human medulloblastoma cells. FASEB J 2010, 24(8):2881-2892. 10.1096/fj.09-148593, 20354138.
-
(2010)
FASEB J
, vol.24
, Issue.8
, pp. 2881-2892
-
-
Rossi, A.1
Schenone, S.2
Angelucci, A.3
Cozzi, M.4
Caracciolo, V.5
Pentimalli, F.6
Puca, A.7
Pucci, B.8
La Montagna, R.9
Bologna, M.10
Botta, M.11
Giordano, A.12
-
21
-
-
0023502622
-
Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system
-
10.1172/JCI113137, 442306, 2887586
-
Thiele CJ, McKeon C, Triche TJ, Ross RA, Reynolds CP, Israel MA. Differential protooncogene expression characterizes histopathologically indistinguishable tumors of the peripheral nervous system. J Clin Invest 1987, 80(3):804-811. 10.1172/JCI113137, 442306, 2887586.
-
(1987)
J Clin Invest
, vol.80
, Issue.3
, pp. 804-811
-
-
Thiele, C.J.1
McKeon, C.2
Triche, T.J.3
Ross, R.A.4
Reynolds, C.P.5
Israel, M.A.6
-
22
-
-
0035882439
-
Ethanol exposure inhibits the cytotoxic effect induced by gp120 in CHP100 human neuroblastoma cells
-
10.1002/jnr.1161, 11494372
-
Navarra M, Romano C, Lorenzon T, Rotiroti D, Di Renzo G. Ethanol exposure inhibits the cytotoxic effect induced by gp120 in CHP100 human neuroblastoma cells. J Neurosci Res 2001, 65:354-361. 10.1002/jnr.1161, 11494372.
-
(2001)
J Neurosci Res
, vol.65
, pp. 354-361
-
-
Navarra, M.1
Romano, C.2
Lorenzon, T.3
Rotiroti, D.4
Di Renzo, G.5
-
23
-
-
34250191484
-
Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro
-
10.1038/sj.bjp.0707237, 2013960, 17401440
-
Corasaniti MT, Maiuolo J, Maida S, Fratto V, Navarra M, Russo R, Amantea D, Morrone LA, Bagetta G. Cell signaling pathways in the mechanisms of neuroprotection afforded by bergamot essential oil against NMDA-induced cell death in vitro. Br J Pharmacol 2007, 151:518-529. 10.1038/sj.bjp.0707237, 2013960, 17401440.
-
(2007)
Br J Pharmacol
, vol.151
, pp. 518-529
-
-
Corasaniti, M.T.1
Maiuolo, J.2
Maida, S.3
Fratto, V.4
Navarra, M.5
Russo, R.6
Amantea, D.7
Morrone, L.A.8
Bagetta, G.9
-
24
-
-
0030569527
-
NMDA and HIV-1 coat protein, GP120, produce necrotic but not apoptotic cell death in human CHP100 neuroblastoma cultures via a mechanism involving calpain
-
10.1006/bbrc.1996.1796, 8954122
-
Corasaniti MT, Navarra M, Catani MV, Melino G, Nisticò G, Finazzi-Agrò A. NMDA and HIV-1 coat protein, GP120, produce necrotic but not apoptotic cell death in human CHP100 neuroblastoma cultures via a mechanism involving calpain. Biochem Biophys Res Commun 1996, 229:299-304. 10.1006/bbrc.1996.1796, 8954122.
-
(1996)
Biochem Biophys Res Commun
, vol.229
, pp. 299-304
-
-
Corasaniti, M.T.1
Navarra, M.2
Catani, M.V.3
Melino, G.4
Nisticò, G.5
Finazzi-Agrò, A.6
-
25
-
-
42349108110
-
Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma
-
10.1158/0008-5472.CAN-07-5032, 18413728
-
Molenaar JJ, Ebus ME, Koster J, van Sluis P, van Noesel CJ, Versteeg R, Caron HN. Cyclin D1 and CDK4 activity contribute to the undifferentiated phenotype in neuroblastoma. Cancer Res 2008, 68:2599-2609. 10.1158/0008-5472.CAN-07-5032, 18413728.
-
(2008)
Cancer Res
, vol.68
, pp. 2599-2609
-
-
Molenaar, J.J.1
Ebus, M.E.2
Koster, J.3
van Sluis, P.4
van Noesel, C.J.5
Versteeg, R.6
Caron, H.N.7
-
26
-
-
0842323936
-
Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression
-
10.1093/jnci/djh004, 14709738
-
Beppu K, Jaboine J, Merchant MS, Mackall CL, Thiele CJ. Effect of imatinib mesylate on neuroblastoma tumorigenesis and vascular endothelial growth factor expression. J Natl Cancer Inst 2004, 96:46-55. 10.1093/jnci/djh004, 14709738.
-
(2004)
J Natl Cancer Inst
, vol.96
, pp. 46-55
-
-
Beppu, K.1
Jaboine, J.2
Merchant, M.S.3
Mackall, C.L.4
Thiele, C.J.5
-
27
-
-
23944524789
-
Antitumor activity of imatinib mesylate in neuroblastoma xenografts
-
10.1016/j.canlet.2005.02.054, 15950376
-
Meco D, Riccardi A, Servidei T, Brueggen J, Gessi M, Riccardi R, Dominici C. Antitumor activity of imatinib mesylate in neuroblastoma xenografts. Cancer Lett 2005, 228:211-209. 10.1016/j.canlet.2005.02.054, 15950376.
-
(2005)
Cancer Lett
, vol.228
, pp. 211-1209
-
-
Meco, D.1
Riccardi, A.2
Servidei, T.3
Brueggen, J.4
Gessi, M.5
Riccardi, R.6
Dominici, C.7
-
28
-
-
38749092531
-
In vitro antiproliferative and antimigratory activity of dasatinib in neuroblastoma and Ewing sarcoma cell lines
-
Timeus F, Crescenzio N, Fandi A, Doria A, Foglia L, Cordero di Montezemolo L. In vitro antiproliferative and antimigratory activity of dasatinib in neuroblastoma and Ewing sarcoma cell lines. Oncol Rep 2008, 19:353-359.
-
(2008)
Oncol Rep
, vol.19
, pp. 353-359
-
-
Timeus, F.1
Crescenzio, N.2
Fandi, A.3
Doria, A.4
Foglia, L.5
Cordero di Montezemolo, L.6
-
29
-
-
70350721795
-
Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model
-
10.1002/ijc.24606, 19623650
-
Vitali R, Cesi V, Nicotra MR, McDowell HP, Donfrancesco A, Mannarino O, Natali PG, Raschellà G, Dominici C. Activity of tyrosine kinase inhibitor Dasatinib in neuroblastoma cells in vitro and in orthotopic mouse model. Int J Cancer 2009, 125:2547-2555. 10.1002/ijc.24606, 19623650.
-
(2009)
Int J Cancer
, vol.125
, pp. 2547-2555
-
-
Vitali, R.1
Cesi, V.2
Nicotra, M.R.3
McDowell, H.P.4
Donfrancesco, A.5
Mannarino, O.6
Natali, P.G.7
Raschellà, G.8
Dominici, C.9
-
30
-
-
37549041711
-
A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study
-
10.1002/pbc.21132, 17262795
-
Bond M, Bernstein ML, Pappo A, Schultz KR, Krailo M, Blaney SM, Adamson PC. A phase II study of imatinib mesylate in children with refractory or relapsed solid tumors: a Children's Oncology Group study. Pediatr Blood Cancer 2008, 50:254-258. 10.1002/pbc.21132, 17262795.
-
(2008)
Pediatr Blood Cancer
, vol.50
, pp. 254-258
-
-
Bond, M.1
Bernstein, M.L.2
Pappo, A.3
Schultz, K.R.4
Krailo, M.5
Blaney, S.M.6
Adamson, P.C.7
-
31
-
-
33847770923
-
Last findings on dual inhibitors of abl and SRC tyrosine-kinases
-
10.2174/138955707779802598, 17305593
-
Schenone S, Manetti F, Botta M. Last findings on dual inhibitors of abl and SRC tyrosine-kinases. Mini Rev Med Chem 2007, 7:191-201. 10.2174/138955707779802598, 17305593.
-
(2007)
Mini Rev Med Chem
, vol.7
, pp. 191-201
-
-
Schenone, S.1
Manetti, F.2
Botta, M.3
-
32
-
-
0030882685
-
High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas
-
Nakagawara A, Nakamura Y, Ikeda H, Hiwasa T, Kuida K, Su MS, Zhao H, Cnaan A, Sakiyama S. High levels of expression and nuclear localization of interleukin-1 beta converting enzyme (ICE) and CPP32 in favorable human neuroblastomas. Cancer Res 1997, 57(20):4578-4584.
-
(1997)
Cancer Res
, vol.57
, Issue.20
, pp. 4578-4584
-
-
Nakagawara, A.1
Nakamura, Y.2
Ikeda, H.3
Hiwasa, T.4
Kuida, K.5
Su, M.S.6
Zhao, H.7
Cnaan, A.8
Sakiyama, S.9
-
33
-
-
0041475779
-
Neuroblastoma: biology and molecular and chromosomal pathology
-
10.1016/S1470-2045(03)01166-5, 12901961
-
Schwab M, Westermann F, Hero B, Berthold F. Neuroblastoma: biology and molecular and chromosomal pathology. Lancet Oncol 2003, 4:472-480. 10.1016/S1470-2045(03)01166-5, 12901961.
-
(2003)
Lancet Oncol
, vol.4
, pp. 472-480
-
-
Schwab, M.1
Westermann, F.2
Hero, B.3
Berthold, F.4
-
34
-
-
0030925761
-
Oncoprotein signalling and mitosis
-
10.1016/S0898-6568(96)00176-3, 9218124
-
Laird AD, Shalloway D. Oncoprotein signalling and mitosis. Cell Signal 1997, 9:249-255. 10.1016/S0898-6568(96)00176-3, 9218124.
-
(1997)
Cell Signal
, vol.9
, pp. 249-255
-
-
Laird, A.D.1
Shalloway, D.2
-
35
-
-
48949118327
-
Growth hormone receptor; mechanism of action
-
10.1016/j.biocel.2007.07.008, 17888716
-
Brooks AJ, Wooh JW, Tunny KA, Waters MJ. Growth hormone receptor; mechanism of action. Int J Biochem Cell Biol 2008, 40:1984-1989. 10.1016/j.biocel.2007.07.008, 17888716.
-
(2008)
Int J Biochem Cell Biol
, vol.40
, pp. 1984-1989
-
-
Brooks, A.J.1
Wooh, J.W.2
Tunny, K.A.3
Waters, M.J.4
-
36
-
-
51349158338
-
Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis
-
10.1016/j.advenzreg.2007.11.002, 2633125, 18155170
-
Johnson DE. Src family kinases and the MEK/ERK pathway in the regulation of myeloid differentiation and myeloid leukemogenesis. Adv Enzyme Regul 2008, 48:98-112. 10.1016/j.advenzreg.2007.11.002, 2633125, 18155170.
-
(2008)
Adv Enzyme Regul
, vol.48
, pp. 98-112
-
-
Johnson, D.E.1
-
37
-
-
20444438759
-
Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest
-
10.1158/1078-0432.CCR-04-2071, 15958613
-
Yaari S, Jacob-Hirsch J, Amariglio N, Haklai R, Rechavi G, Kloog Y. Disruption of cooperation between Ras and MycN in human neuroblastoma cells promotes growth arrest. Clin Cancer Res 2005, 11:4321-4330. 10.1158/1078-0432.CCR-04-2071, 15958613.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 4321-4330
-
-
Yaari, S.1
Jacob-Hirsch, J.2
Amariglio, N.3
Haklai, R.4
Rechavi, G.5
Kloog, Y.6
-
38
-
-
61349123614
-
The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells
-
10.1111/j.1471-4159.2009.05883.x, 2677392, 19183271
-
Lee HP, Zhu X, Zhu X, Skidmore SC, Perry G, Sayre LM, Smith MA, Lee HG. The essential role of ERK in 4-oxo-2-nonenal-mediated cytotoxicity in SH-SY5Y human neuroblastoma cells. J Neurochem 2009, 108:1434-1441. 10.1111/j.1471-4159.2009.05883.x, 2677392, 19183271.
-
(2009)
J Neurochem
, vol.108
, pp. 1434-1441
-
-
Lee, H.P.1
Zhu, X.2
Zhu, X.3
Skidmore, S.C.4
Perry, G.5
Sayre, L.M.6
Smith, M.A.7
Lee, H.G.8
-
39
-
-
33748068089
-
New concepts regarding focal adhesion kinase promotion of cell migration and proliferation
-
10.1002/jcb.20956, 16823799
-
Cox BD, Natarajan M, Stettner MR, Gladson CL. New concepts regarding focal adhesion kinase promotion of cell migration and proliferation. J Cell Biochem 2006, 99(1):35-52. 10.1002/jcb.20956, 16823799.
-
(2006)
J Cell Biochem
, vol.99
, Issue.1
, pp. 35-52
-
-
Cox, B.D.1
Natarajan, M.2
Stettner, M.R.3
Gladson, C.L.4
|